Considering the contribution of percutaneous priming for the development of atopic march, a progression from eczema to allergic rhinitis and asthma [26, 27], their finding may suggest that IL-22 plays a role in percutaneous sensitization and thus the development of asthma in patients with eczema. This evidence concerns the gene IL22 and asthma.